Can I-124 PET/CT Predict Pathological Uptake of Therapeutic Dosages of Radioiodine (I-131) in Differentiated Thyroid Carcinoma?
Advances in Molecular Imaging · 2014
DOI: 10.4236/ami.2014.43004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Molecular Imaging, 2014. Verfasst von Gauke K. Lammers und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lammers, G. K., Esser, J. P., Pasker, P. C. M., Praag, M. E. S., & Klerk, J. M. H. D. (2014). Can I-124 PET/CT Predict Pathological Uptake of Therapeutic Dosages of Radioiodine (I-131) in Differentiated Thyroid Carcinoma?. Advances in Molecular Imaging. https://doi.org/10.4236/ami.2014.43004
Vancouver
Lammers GK, Esser JP, Pasker PCM, Praag MES, Klerk JMHD. Can I-124 PET/CT Predict Pathological Uptake of Therapeutic Dosages of Radioiodine (I-131) in Differentiated Thyroid Carcinoma?. Advances in Molecular Imaging. 2014. doi:10.4236/ami.2014.43004
BibTeX
@article{Lammers2014,
author = {Lammers, Gauke K. and Esser, Jan Paul and Pasker, Pieternel C. M. and Praag, Marina E. Sanson-van and Klerk, John M. H. de},
title = {Can I-124 PET/CT Predict Pathological Uptake of Therapeutic Dosages of Radioiodine (I-131) in Differentiated Thyroid Carcinoma?},
journal = {Advances in Molecular Imaging},
year = {2014},
doi = {10.4236/ami.2014.43004}
}
EUVIMED